Navigation Links
Visiprise Named One of the Top Manufacturing Technology Providers
Date:3/26/2008

ATLANTA, March 26 /PRNewswire/ -- Visiprise, Inc., a leader in manufacturing execution systems (MES) for the integrated enterprise, announced today it has been named to START-IT magazine's START-IT 125 list.

The START-IT 125 list is compiled by the editors and editorial advisors of START-IT magazine to recognize the top companies providing technology solutions to the manufacturing market.

Visiprise's flagship solution, Visiprise Manufacturing, is a manufacturing execution system (MES) for discrete manufacturers. The solution captures, shares, and stores manufacturing data while integrating with ERP, PLM and other business systems to provide complete visibility across the manufacturing enterprise.

"Each year, we see more change in the manufacturing industry and the available technology, and each year the editors of START-IT must be more critical in examining the top 125 technology providers," said Peggy Smedley, editorial director of START-IT. "The START-IT 125 lets our readers know what the best solutions are, who can provide them, and how they can help manufacturers improve business practices."

This recognition continues the momentum that began in 2005 when Visiprise was named to the publication's 2005 Hottest Companies list. In 2006 Visiprise was named to the Hottest Companies list and was picked as one of only three MES vendors to be recognized on the 2006 START-IT 125 list. In 2007 Visiprise was again selected for the START-IT 125 list and gained further recognition when Visiprise Manufacturing was selected as one of START-IT's top 50 technologies.

"We continue to maintain our position as an MES market leader," said Carter Johnson, senior vice president of corporate development at Visiprise. "Our achievements in 2007 are leading to success in new markets and geographies in 2008. This recognition reflects a consistent record of success that our company has worked diligently to achieve on behalf of our customers and partne
'/>"/>

SOURCE Visiprise, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Visiprise Launches Podcast Series with AMR to Support Medical Device Manufacturers
2. Harman/Becker Automotive Systems Completes Initial Deployments of Visiprise Integrated Manufacturing Execution
3. E-Z-GO and Visiprise to Participate in New Product Introduction Event with IndustryWeek
4. Heartline(R) Fitness Systems Named to Inc. Magazines Inaugural List of the 5000 Fastest Growing Private Companies in U.S....
5. Allscripts Named to FORTUNE 100 Fastest-Growing Companies List
6. Boston Micromachines Multi-DM Named One of the Years Most Innovative Products
7. Karen Vigil Named Senior Vice President and Chief Executive Officer, Blue Shield of Californias Individual, Small Group, and Government Business Unit
8. New Director of Nursing Practice Named for Nurses Association
9. Instrumentation Laboratory Named Top of Class by Respiratory Care Managers
10. Meeting Expectations Named to First Annual CMI 25 List by Corporate Meetings & Incentives Magazine
11. Frances Decker Named Mid-Atlantic Region Sales Executive for AllOne Health Management Solutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2009)--In Youngest Babies, This Type of Blood Cancer Is Most Challenging-- ,, PHILADELPHIA and NEW ORLEANS, Dec. 5 Pediatric oncologists have identified specific genes, dubbed partner genes, that fuse w
(Date:12/5/2009)AVIVA today announced the launch of International Solutions, an innovative new international private medical insurance plan which follows the acclaimed modular design of its UK equivalent. In addition
(Date:12/4/2009)NEW YORK, Dec. 4 Thousands of KPMG LLP employees came together in more than 90 offices nationwide today, to participate in a community service event which combines the audit, tax and advisory firm,s
(Date:12/4/2009)KANSAS CITY, Mo., Dec. 4 The large, two-day free health clinic sponsored by the National Association of Free Clinics (NAFC) in Kansas City on Wednesday and Thursday is not just for the sick but also
(Date:12/4/2009)Late recurrence is a risk for some pediatric cancers, particularly Ewing sarcomas and tumors of the central nervous system, according to a new study published online December 4 in the Journal of the
Breaking Medicine News(10 mins):Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 2Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 3Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 4Health News:AVIVA's Private Health Insurance Products Solutions Go International 2Health News:KPMG Employees Provide 'Holiday Bear Hugs' and Books in Firmwide Service Day for Children 2Health News:Free Health Clinic Event Is Not Just for the Sick 2
...Supporter Says Her Bulldog Loved Cats, Dog Would W...y Cat Campaign , , DENVER, March 19 Memorializin...health may seem unusual. Yet Florida resident Judi...Cat Campaign , which was launched in November to r...
...ing to Support Increasing Sales of the Company,s I...ch 19 MedAptus(R), market leader for charge captu...ed $6 million in capital in a financing led by exi...f products. , , "The realities of today,s economy...
...RFAX, Va.Matthew A. Mauro, M.D., FSIR, delivered t...ty of Interventional Radiology,s 34th Annual Scien...award, supported by the SIR Foundation, honors an ...l radiology. , Mauro, who addressed "The Birth of...
...ing out, lack of social support and high-risk life...ients with type 2 diabetes from controlling their ...ered 8,900 patients and 4,550 healthcare providers..., socioeconomic, physical, environmental and cultu...
...TSDALE, Ariz., March 19 Clinical Information Netw...today that Robert J. LaBuda has joined its board o...ny in late 2008, LaBuda was the executive at Merck...s Inside Sales & Customer Services. , , "Bob ...
...oins the Field Museum for World Water Day March 22...es (UL), a world leader in product safety testing ...vation educational campaign in the East Wing of th...ng commitment to public health and safety, UL aims...
Other Medicine News:Health News:Animal Lover Memorializes Beloved Bulldog Who Loved Cats - Makes Gift to Improve Feline Health 2Health News:Animal Lover Memorializes Beloved Bulldog Who Loved Cats - Makes Gift to Improve Feline Health 3Health News:MedAptus Secures $6 Million Investment 2Health News:Society of Interventional Radiology honors Dotter lecturer, announces gold medalists 2Health News:Society of Interventional Radiology honors Dotter lecturer, announces gold medalists 3Health News:Society of Interventional Radiology honors Dotter lecturer, announces gold medalists 4Health News:Barriers to diabetes care include restaurants and high-risk lifestyles, says international review 2Health News:Barriers to diabetes care include restaurants and high-risk lifestyles, says international review 3Health News:Former Merck Executive Joins Board of Clinical Information Network, Inc. 2Health News:World Water Day 2009 Marks Launch of UL's Yearlong Commitment to Water Quality and Conservation Education 2Health News:World Water Day 2009 Marks Launch of UL's Yearlong Commitment to Water Quality and Conservation Education 3
(Date:12/4/2009)BETHESDA, Md., Dec. 4 Drs. Neal Shore and E. David Crawford presented results for prostate-specific antigen (PSA) recurrence from the additional analysis of secondary end points of biochemical recurr
(Date:12/4/2009)RARITAN, N.J., Dec. 4 Depression, anxiety disorder, bipolar disorder, Attention Deficit Hyperactivity Disorder (ADHD), sleep disorder and migraine: These are among the comorbidities reported to occur
(Date:12/3/2009)ALISO VIEJO, Calif. and STATE COLLEGE, Pa., Dec. 3 Ambry Genetics and SoftGenetics today announced the signing of an agreement to provide extended bioinformatics genomics services using SoftGenetics,
Breaking Medicine Technology:Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 2Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 3Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 2Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 3Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 1Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 2Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 3Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 4Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 5Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 6Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 7Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 8Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 9PDL BioPharma to Present at BioCentury Newsmakers Conference on September 16 2009 56592 1Major clinical study rejects cancer safety fears of most common heartburn treatment 56590 1Major clinical study rejects cancer safety fears of most common heartburn treatment 56590 2
...ith the continued aging of,the population and the ...f,the disease is crucial for risk assessment, test... with better drugs, once they are developed.,Four ...ion,s 2008,International Conference on Alzheimer,s... that goal of early detection by describing advanc...
...29 Bladder problems may,leave a mark on the brain...,contributing to disrupted sleep and problems with...active bladder, the involuntary bladder contractio...te, such mind-body,connections may be of more than...ust one organ, but here we see how an,abnormal org...
Other Medicine Technology:Markers in Blood and Spinal Fluid, and a New Imaging Agent, Show Promise for Early Detection of Alzheimer's 2Markers in Blood and Spinal Fluid, and a New Imaging Agent, Show Promise for Early Detection of Alzheimer's 3Markers in Blood and Spinal Fluid, and a New Imaging Agent, Show Promise for Early Detection of Alzheimer's 4Markers in Blood and Spinal Fluid, and a New Imaging Agent, Show Promise for Early Detection of Alzheimer's 5Markers in Blood and Spinal Fluid, and a New Imaging Agent, Show Promise for Early Detection of Alzheimer's 6Markers in Blood and Spinal Fluid, and a New Imaging Agent, Show Promise for Early Detection of Alzheimer's 7Markers in Blood and Spinal Fluid, and a New Imaging Agent, Show Promise for Early Detection of Alzheimer's 8Findings on Bladder-Brain Link May Point to Better Treatments for Problems in Sleep, Attention 2
...logy, the wire crosses the lesion first, independe...actions, including filter placement and retrieval,...ur over the wire., ,Emboshield is designed to ... stenting procedure, and it is the only filter to ...
...oratory has been uniquely designed to fit the need...ning multi-facilities. From test initiation and pr...ivable, Centricity Ultra facilitates quick, effici...modules are fully integrated and reside under a si...
MICROWELL ELISA HUMAN GROWTH HORMONE (hGH) ENZYME IMMUNOASSAY TEST KIT
...ne sulfate (DHEA-S) is the sulfate ester of DHEA, ...conversion of DHEA in adrenal and extradrenal tiss... adrenal cortex, and is a precursor for testostero...ively weak androgenic activity, which for unsulfat...
Medicine Products: